The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dermatologic toxicities of 3,517 solid tumor patients on phase I clinical trials of the National Institutes of Health Cancer Therapy Evaluation Program (CTEP).
 
Alexander E. Drilon
Honoraria - Exelixis; Genentech/Roche; Ignyta
Consulting or Advisory Role - Exelixis; Genentech/Roche
Speakers' Bureau - Ignyta
Research Funding - Foundation Medicine
Travel, Accommodations, Expenses - Exelixis; Genentech/Roche; Ignyta
 
Anne Eaton
No Relationships to Disclose
 
Katja Schindler
No Relationships to Disclose
 
Mrinal M. Gounder
No Relationships to Disclose
 
Gary L. Smith
No Relationships to Disclose
 
Diana Vulih
No Relationships to Disclose
 
Pamela Jo Harris
No Relationships to Disclose
 
David R. Spriggs
Patents, Royalties, Other Intellectual Property - Through my laboratory, we haver discovered anti-MUC16 antibodies that MSKCC has filed patents about. These patents, if commercialized could ultimately result in royalties paid to me. (Inst)
 
Percy Ivy
No Relationships to Disclose
 
Alexia Iasonos
No Relationships to Disclose
 
Mario E. Lacouture
Honoraria - Advancell; Aveo; Bayer; BIOPHARM; Boehringer Ingelheim; Brickell Biotech; Bristol-Myers Squibb; Clinical Assistance Programs LLC; Clinical Care Options; EMD Serono; Envision Communications; Foamix; Galderma; Genentech/Roche; GlaxoSmithKline; Helsinn Healthcare; Helsinn Healthcare; Medscape; Merck; NeRRe Therapeutics; Novartis; Novocure; Oncology Specialty Group; Pfizer; Pierre Fabre; Threshold Pharmaceuticals
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Brickell Biotech; Bristol-Myers Squibb; EMD Serono; Foamix; Galderma; Genentech/Roche; GlaxoSmithKline; Helsinn Healthcare; Merck; Novartis; Novocure; Pfizer; Pierre Fabre; Threshold Pharmaceuticals
Research Funding - Berg Pharma (Inst)
 
David Michael Hyman
No Relationships to Disclose